20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
- Thermo Fisher Scientific Inc (NYSE:TMO) is close to acquiring UK-based diagnostic firm Binding Site from private equity fund Nordic Capital.
- The lab equipment and supplies giant is reportedly paying more than £2 billion ($2.3 billion) for the deal.
- Binding Site is developing diagnostic products to detect immune-system disorders and caters to clinicians and laboratory professionals.
- Also Read: Thermo Fisher Q3 Earnings Beat Street View, With 14% Organic Sales Growth.
- The agreement could be announced as early as this week, Bloomberg reported citing people familiar with the matter.
- The deal would mark a revival to dealmaking in Europe, where volumes collapsed this quarter, the report added.
- The talks are advanced, but there’s no certainty the deal will go through.
- Last year, Thermo Fisher acquired PPD Inc, a provider of clinical and research services, for $17.4 billion. In January, it bought PeproTech, a closely held provider of recombinant proteins, for about $1.85 billion cash.
- Price Action: TMO shares closed at $503.84 on Friday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!